Remedy Robotics raises $35M Series A to scale remote surgical robotics platform
Evidence notes
- Named investors or backers include DCVC, Blackbird Ventures.
- The financing supports continued development, regulatory progress, or deployment of healthcare robotics systems.
Company context
Develops remotely operated endovascular surgical robotic systems designed for neurovascular and cardiovascular interventions. The company's platform enables catheter-based procedures to be performed with robotic precision and remote teleoperation capabilities.